Inhibitory effect of mycophenolic acid on the replication of infectious pancreatic necrosis virus and viral hemorrhagic septicemia virus

Antiviral Research

Volumn 80, Issue 3, 2008, Pages 332-338

  Marroquí, Laura ^a   Estepa, Amparo ^a   Perez, Luis ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

Antivirals; IPNV; Real time RT PCR; VHSV

Indexed keywords

INOSINATE DEHYDROGENASE; MYCOPHENOLIC ACID; RIBAVIRIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; INFECTIOUS PANCREATIC NECROSIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAINBOW TROUT; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS; VIRUS INHIBITION;

INFECTIOUS PANCREATIC NECROSIS VIRUS; ONCORHYNCHUS MYKISS; SALMONIDAE; VIRAL HEMORRHAGIC SEPTICEMIA VIRUS;

EID: 56349130560     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2008.07.007     Document Type: Article

References (33)

1. Chico V., Gomez N., Estepa A., and Perez L. Rapid detection and quantitation of viral hemorrhagic septicemia virus in experimentally challenged rainbow trout by real-time RT-PCR. J. Virol. Methods 132 (2006) 154-159
2. Chung D.-H., Sun Y., Parker W.B., Arterburn J.B., Bartolucci A., and Jonsson C.B. Ribavirin reveals a lethal threshold of allowable mutation frequency for hantaan virus. J. Virol. 81 (2007) 11722-11729
3. Diamond M.S., Zachariah M., and Harris E. Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA. Virology 304 (2002) 211-221
4. Falco A., Mas V., Tafalla C., Perez L., Coll J.M., and Estepa A. Dual antiviral activity of human alpha-defensin-1 against viral haemorrhagic septicaemia rhabdovirus (VHSV): Inactivation of virus particles and induction of a type I interferon-related response. Antivir. Res. 76 (2007) 111-123
5. Goswami B.B., Borek E., and Sharma O.K. The broad-spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem. Biophys. Res. Commun. 89 (1979) 830-836
6. Graci J.D., and Cameron C.E. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology 298 (2002) 175-180
7. Graci J.D., and Cameron C.E. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16 (2006) 49-63
8. Hermann L.L., and Coombs K.M. Inhibition of reovirus by mycophenolic acid is associated with the M1 genome segment. J. Virol. 78 (2004) 6171-6179
9. Hudson J.B., Graham E.A., and Simpson M.F. The efficacy of amantadine and other antiviral compounds against two salmonid viruses in vitro. Antivir. Res. 9 (1988) 379-385
10. Jashés M., Mlynarz G., De Clercq E., and Sandino A.M. Inhibitory effects of EICAR on infectious pancreatic necrosis virus replication. Antivir. Res. 45 (2000) 9-17
11. Kamei Y., and Aoki M. A chlorophyll c2 analogue from the marine brown alga Eisenia bicyclis inactivates the infectious hematopoietic necrosis virus, a fish rhabdovirus. Arch. Virol. 152 (2007) 861-869
12. LaPatra S.E., Lauda K.A., Jones G.R., Shewmaker W.S., and Bayne C.J. Resistance to IHN virus infection in rainbow trout is increased by glucan while subsequent production of serum neutralizing activity is decreased. Fish Shellfish Immunol. 8 (1998) 435-446
13. LeBerre M., DeKinkelin P., and Metzger A. Identification sérologique des rhabdovirus des salmonidés. Bull. Office Int. Epizooties 87 (1977) 391-393
14. Leyssen P., Balzarini J., De Clercq E., and Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. J. Virol. 79 (2005) 1943-1947
15. Leyssen P., De Clercq E., and Neyts J. The anti-yellow fever virus activity of ribavirin is independent of error-prone replication. Mol. Pharmacol. 69 (2006) 1461-1467
16. Lorenzo G., Estepa A., and Coll J.M. Fast neutralization immunoperoxidase assay for viral haemorrhagic septicaemia with anti-nucleoprotein monoclonal antibody. J. Virol. Methods 58 (1996) 1-6
17. Markland W., McQuaid T.J., Jain J., and Kwong A.D. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 44 (2000) 859-866
18. Marroquí L., Estepa A., and Perez L. Assessment of the inhibitory effect of ribavirin on the rainbow trout rhabdovirus VHSV by real-time reverse-transcription PCR. Vet. Microbiol. 122 (2007) 52-60
19. Mas V., Rocha A., Perez L., Coll J.M., and Estepa A. Reversible inhibition of spreading of in vitro infection and imbalance of viral protein accumulation at low pH in viral hemorrhagic septicemia rhabdovirus, a salmonid rhabdovirus. J. Virol. 78 (2004) 1936-1944
20. Mas V., Falco A., Brocal I., Perez L., Coll J.M., and Estepa A. Identification of selective inhibitors of VHSV from biased combinatorial libraries of N,N′-disubstituted 2,5-piperazinediones. Antivir. Res. 72 (2006) 107-115
21. Micol V., Caturla N., Pérez-Pons L., Mas V., Perez L., and Estepa A. The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antivir. Res. 66 (2005) 129-136
22. Migus D.O., and Dobos P. Effect of ribavirin on the replication of infectious pancreatic necrosis virus in fish cell cultures. J. Gen. Virol. 47 (1980) 47-57
23. Moya J., Pizarro H., Jashés M., De Clercq E., and Sandino A.M. In vivo effect of EICAR (5-ethynyl-1-b-d-ribofuranosylimidazole-carboxamide) on experimental infected rainbow trout (Oncorhynchus mykiss) and coho salmon fry with infectious pancreatic necrosis virus. Antivir. Res. 48 (2000) 125-130
24. Parker W.B. Metabolism and antiviral activity of ribavirin. Virus Res. 107 (2005) 165-171
25. Perez L., Mas V., Coll J.M., and Estepa A. Enhanced detection of viral hemorrhagic septicemia virus (a salmonid rhabdovirus) by pretreatment of the virus with a combinatorial library-selected peptide. J. Virol. Methods 106 (2002) 17-23
26. Rankin J.T. Studies of the mechanism of the antiviral activity of ribavirin against reovirus. Virology 168 (1989) 147-158
27. Robertson C.M., Hermann L.L., and Coombs K.M. Mycophenolic acid inhibits avian reovirus replication. Antivir. Res. 64 (2004) 55-61
28. Sintchak M.D., Fleming M.A., Futer O., Raybuck S.A., Chambers S.P., Caron P.R., Murcko M.A., and Wilson K.P. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 85 June 14 (6) (1996) 921-930 1996
29. Smee D.F., Bray M., and Huggins J.W. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro. Antivir. Chem. Chemother. 12 (2002) 327-335
30. Stuyver L.J., Lostia S., Patterson J.L., Clark J.L., Watanabe K.A., Otto M.J., and Pankiewicz K.W. Inhibitors of the IMPDH enzyme as potential anti-bovine viral diarrhoea virus agents. Antivir. Chem. Chemother. 13 (2002) 345-352
31. Sun Y., Chung D.-H., Chu Y.-K., Jonsson C.B., and Parker W.B. Activity of ribavirin against hantaan virus correlates with production of ribavirin-5′-triphosphate, not with inhibition of IMP dehydrogenase. Antimicrob. Agents Chemother. 51 (2007) 84-88
32. Takhampunya R., Ubol S., Houng H.-S., Cameron C.E., and Padmanabhan R. Inhibition of dengue virus replication by mycophenolic acid and ribavirin. J. Gen. Virol. 87 (2006) 1947-1952
33. Toltzis P., O'Connell K., and Patterson J.L. Effect of phosphorylated ribavirin on vesicular stomatitis virus transcription. Antimicrob. Agents Chemother. 32 (1988) 492-497